Fundraising FoxVHM — Full Portfolio
3 tracked investments · listed companies and verified rows first
Rani Therapeutics develops oral drug delivery technology using robotic capsules to replace injectable biotherapeutics, addressing the challenge of delivering biologics through the gastrointestinal tract without needles.
BiotechDigital HealthHealthtechMedical DevicesSan Jose, US
Mir Hashim(Executive Officer, Director)inTalat Imran(Chief Executive Officer)in
BoardMir Imran(Founder)
Board seatAndrew Farquharson· per SEC Form D · $52.3M raise · filed Jun 2015
Co-investorsGV (Google Ventures)InCube VenturesRA Capital
HealthtechEmeryville, US
Bill Malecki(Executive Officer)Daniel Burnett(Director)Ulric Cote(Executive Officer, Director)
BoardDr. Jason Hong(Director)Anthony Natale(Director)inCarter Mayer(Director)
Board seatAndrew Farquharson· per SEC Form D · $29.5M raise · filed Jul 2015
Co-investorsAPERTURE Venture PartnersGreen Park & Golf VenturesScientific Health DevelopmentThird Point VenturesLongwood Fund
Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Brian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)
BoardJak Knowles(Director)
Board seatAndrew Farquharson· per SEC Form D · $27.3M raise · filed Aug 2019
Co-investorsCatalio Capital Management, LPRA CapitalSozo VenturesAgent CapitalFrazier Life SciencesHumboldt+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.